Further, increased activation of STAT3 and its target genes, such as survivin, is often associated with tumor resistance to chemotherapy and radiotherapy in the brain, breast, colon, rectum, head, neck, and lung [21, 25]. The gene discussed is STAT3; the disease is neoplasm.